aTyr Pharma, Inc.ATYRNASDAQ
Loading
Net Income Growth Recovery in ProgressRecovering
Percentile Rank46
Studio
Year-over-Year Change

Year-over-year net income growth rate

Percentile
P46
Within normal range
vs 5Y Ago
-0.5x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-15.77%
2024-27.06%
2023-11.14%
2022-34.26%
2021-108.14%
202031.26%
201931.62%
201828.40%
201716.68%
2016-20.60%